Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

The influence of chronic renal failure on the spectrum and antimicrobial susceptibility of uropathogens in community-acquired acute pyelonephritis presenting as a positive urine culture

Authors: Yeon Soon Jung, Ho Sik Shin, Hark Rim

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

The role of chronic renal failure (CRF) in the antimicrobial resistance of uropathogens in patients with community-acquired acute pyelonephritis (APN) remains poorly understood.

Method

We performed a retrospective analysis of 502 adults (54 men, 448 women; mean age 61.7 ± 16.0 years, range 18-98 years) who were treated for community-acquired APN at Kosin University Gospel Hospital (Busan, Republic of Korea) during a ten-year period (January 2000 to December 2009). We evaluated the spectra and antimicrobial susceptibility profiles of uropathogens in CRF and non-CRF patients with community-acquired APN that presented as a positive urine culture.

Results

The 502 adult subjects were classified as either non-CRF APN patients (336 patients, 66.9%) or CRF APN patients (166 patients, 33.1%) according to their estimated glomerular filtration rate. No significant differences in the sensitivity of E. coli to a third cephalosporin, aminoglycoside (except gentamycin), or ciprofloxacin were observed between non-CRF and CRF patients.

Conclusions

In our series of patients with community-acquired APN that initially presented as a positive urine culture, CRF did not influence the isolation rates of different uropathogens or their patterns of susceptibility to antimicrobials.
Literature
1.
go back to reference Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med. 1993, 329: 1328-34. 10.1056/NEJM199310283291808.CrossRefPubMed Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med. 1993, 329: 1328-34. 10.1056/NEJM199310283291808.CrossRefPubMed
2.
go back to reference Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997, 11: 551-81. 10.1016/S0891-5520(05)70373-1.CrossRefPubMed Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997, 11: 551-81. 10.1016/S0891-5520(05)70373-1.CrossRefPubMed
3.
go back to reference Gupta K, Hooton TM, Wobbe CL, Stamm WE: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents. 1999, 11: 305-8. 10.1016/S0924-8579(99)00035-7.CrossRefPubMed Gupta K, Hooton TM, Wobbe CL, Stamm WE: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents. 1999, 11: 305-8. 10.1016/S0924-8579(99)00035-7.CrossRefPubMed
4.
go back to reference Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE: Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005, 142: 20-7.CrossRefPubMedPubMedCentral Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE: Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005, 142: 20-7.CrossRefPubMedPubMedCentral
5.
go back to reference Bonadio M, Costarelli S, Morelli G, Tartaglia T: The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006, 6: 54-10.1186/1471-2334-6-54.CrossRefPubMedPubMedCentral Bonadio M, Costarelli S, Morelli G, Tartaglia T: The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006, 6: 54-10.1186/1471-2334-6-54.CrossRefPubMedPubMedCentral
6.
go back to reference Descamps-Latscha B, Chatenoud L: T cells and b cells in chronic renal failure. Semin Nephrol. 1996, 16: 183-91.PubMed Descamps-Latscha B, Chatenoud L: T cells and b cells in chronic renal failure. Semin Nephrol. 1996, 16: 183-91.PubMed
7.
go back to reference Bergman SJ, Speil C, Short M, Koirala J: Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations. Infect Dis Clin North Am. 2007, 21: 821-46. 10.1016/j.idc.2007.07.004.CrossRefPubMed Bergman SJ, Speil C, Short M, Koirala J: Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations. Infect Dis Clin North Am. 2007, 21: 821-46. 10.1016/j.idc.2007.07.004.CrossRefPubMed
8.
go back to reference Safrin S, Siegel D, Black D: Pyelonephritis in adult women: Inpatient versus outpatient therapy. Am J Med. 1988, 85: 793-8. 10.1016/S0002-9343(88)80023-8.CrossRefPubMed Safrin S, Siegel D, Black D: Pyelonephritis in adult women: Inpatient versus outpatient therapy. Am J Med. 1988, 85: 793-8. 10.1016/S0002-9343(88)80023-8.CrossRefPubMed
9.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-40. 10.1016/0196-6553(88)90053-3.CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988, 16: 128-40. 10.1016/0196-6553(88)90053-3.CrossRefPubMed
10.
go back to reference Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003, 26 (1): S5-20. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003, 26 (1): S5-20.
11.
go back to reference Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006, 354: 2473-83. 10.1056/NEJMra054415.CrossRefPubMed Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006, 354: 2473-83. 10.1056/NEJMra054415.CrossRefPubMed
12.
go back to reference Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G: Clinical practice guidelines for chronic kidney disease in adults: Part i. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004, 70: 869-76.PubMed Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G: Clinical practice guidelines for chronic kidney disease in adults: Part i. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004, 70: 869-76.PubMed
13.
go back to reference Jorgensen JH, Hindler JF: New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis. 2007, 44: 280-6. 10.1086/510431.CrossRefPubMed Jorgensen JH, Hindler JF: New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis. 2007, 44: 280-6. 10.1086/510431.CrossRefPubMed
15.
go back to reference Nicolle LE: Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008, 35: 1-12. 10.1016/j.ucl.2007.09.004.CrossRefPubMed Nicolle LE: Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008, 35: 1-12. 10.1016/j.ucl.2007.09.004.CrossRefPubMed
16.
go back to reference Bonadio M, Meini M, Spitaleri P, Gigli C: Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001, 40: 439-44. 10.1159/000049813. discussion 445CrossRefPubMed Bonadio M, Meini M, Spitaleri P, Gigli C: Current microbiological and clinical aspects of urinary tract infections. Eur Urol. 2001, 40: 439-44. 10.1159/000049813. discussion 445CrossRefPubMed
17.
18.
go back to reference Bean DC, Krahe D, Wareham DW: Antimicrobial resistance in community and nosocomial escherichia coli urinary tract isolates, london 2005-2006. Ann Clin Microbiol Antimicrob. 2008, 7: 13-10.1186/1476-0711-7-13.CrossRefPubMedPubMedCentral Bean DC, Krahe D, Wareham DW: Antimicrobial resistance in community and nosocomial escherichia coli urinary tract isolates, london 2005-2006. Ann Clin Microbiol Antimicrob. 2008, 7: 13-10.1186/1476-0711-7-13.CrossRefPubMedPubMedCentral
19.
go back to reference Gupta K, Hooton TM, Stamm WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001, 135: 41-50.CrossRefPubMed Gupta K, Hooton TM, Stamm WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001, 135: 41-50.CrossRefPubMed
20.
go back to reference van der Starre WE, van Nieuwkoop C, Paltansing S, Van't Wout JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT: Risk factors for fluoroquinolone-resistant escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2010, 1-7. van der Starre WE, van Nieuwkoop C, Paltansing S, Van't Wout JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT: Risk factors for fluoroquinolone-resistant escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother. 2010, 1-7.
21.
go back to reference Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol. 2006, 17: 2034-47. 10.1681/ASN.2005101085.CrossRefPubMed Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol. 2006, 17: 2034-47. 10.1681/ASN.2005101085.CrossRefPubMed
22.
go back to reference Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol. 2001, 12: 1713-20.PubMed Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol. 2001, 12: 1713-20.PubMed
23.
go back to reference Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005, 16: 3728-35. 10.1681/ASN.2005040384.CrossRefPubMed Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005, 16: 3728-35. 10.1681/ASN.2005040384.CrossRefPubMed
Metadata
Title
The influence of chronic renal failure on the spectrum and antimicrobial susceptibility of uropathogens in community-acquired acute pyelonephritis presenting as a positive urine culture
Authors
Yeon Soon Jung
Ho Sik Shin
Hark Rim
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-102

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.